Systematic review: Autoimmune encephalitis related to cancer treatment with immune checkpoint inhibitors – nivolumab was responsible for 61% of cases; onset occurred after a median of 3.5 treatment cycles, but very early and late presentations were common
20 May, 2021 | 08:13h | UTCAutoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review – Neurology (link to abstract – $ for full-text)